Executives
Executives
BioRev pursues next-generation healthcare through both business development and research & development. Our management team leads brand building, product development, and global expansion, while our R&D organization is led by experts in biopharmaceuticals and natural product chemistry, balancing scientific rigor with business viability.
CEO
Mina Yoshizaki
吉崎美奈
Founder of BioRev. Guided by the belief in rebuilding human health from the cellular level, she oversees product development, brand strategy, business strategy, and global expansion.
Drawing on cross-border business experience centered on Japan, China, and Hong Kong, she drives BioRev's growth as an R&D-driven healthcare brand.
Beyond simple product sales, she aims to build a new healthcare model that combines experience, data, and continuous support.
Global Expansion
Cross-border business centered on Japan, China, and Hong Kong
R&D-Driven Brand
Evidence-based product development and business strategy
New Healthcare Model
Innovative approach combining experience, data, and continuous support
Director, Head of R&D
Dr. Shengxiang Qiu
Shengxiang Qiu, Ph.D. ／ Professor
Dr. Qiu is a researcher with extensive achievements in biopharmaceuticals, natural product chemistry, and neuroscience.
He has served as a doctoral advisor at the Chinese Academy of Sciences and earned his Ph.D. in Pharmaceutical Sciences in the United States. He has also worked internationally as a Principal Scientist at Actavis Group and as a Senior Researcher at Case Western Reserve University School of Medicine.
At BioRev, he leads the core of R&D related to plant-derived ingredients and advanced bio-technologies, supporting evidence-based product development.
Career Highlights
Chinese Academy of Sciences
Doctoral Advisor
Ph.D. in Pharmaceutical Sciences
United States
Former Actavis Group
Principal Scientist
Former Case Western Reserve University
Senior Researcher, School of Medicine